Tizhe Daniel Thakuma, Kwaga Jacob Kwada Paghi, Nok Kia Grace Sabo
Department of Biochemistry, Ahmadu Bello University, Zaria 810106, Nigeria.
African Centre of Excellence for Neglected Tropical Diseases and Forensic Biotechnology, Ahmadu Bello University, Zaria 810106, Nigeria.
Vaccines (Basel). 2022 Aug 28;10(9):1407. doi: 10.3390/vaccines10091407.
Dengue is a disease caused by the dengue virus that is primarily transmitted by mosquitoes. Currently, the disease poses a threat to public health, with about 390 million people reported to be infected annually across the endemic regions of the world. In Nigeria, the disease is under-reported and often misdiagnosed as malaria. This study was designed to conduct a serological and molecular survey for dengue virus infection in febrile patients in three Local Government Areas (LGAs) in Adamawa State, Nigeria, from September through December 2020. Serum samples from 424 patients were analysed by Enzyme-Linked Immunosorbent Assay (CALBIOTECH, Dengue Virus IgM ELISA). Thick and thin smear microscopic techniques were used to determine the presence of malaria parasites. Overall, 19.4% patients were sero-positive for dengue in the three study locations. A total of 11%, 14.5% and 12.3% participants were found to be co-infected with dengue and malaria in Mubi, Jimeta and Numan, respectively. The CDC DENV1-4 RT-PCR Assay reagent was used for serotype-specific detection and identification of circulating serotypes. From the ELISA-positive samples, 11 (2.6%) cases were confirmed to be dengue serotype 1 by Real-Time PCR and sequencing and were found to be in circulation in all the three study areas. With an overall sero-prevalence of 19.4%, dengue virus infection may be one of the major causes of febrile illnesses across the study locations; hence, public healthcare professionals should not neglect other aetiologies of febrile illnesses and the need to conduct laboratory diagnoses to determine the possible causes of febrile illnesses.
登革热是一种由登革病毒引起的疾病,主要通过蚊子传播。目前,该疾病对公共卫生构成威胁,据报道,全球流行地区每年约有3.9亿人感染。在尼日利亚,该疾病报告不足,且常被误诊为疟疾。本研究旨在对2020年9月至12月期间尼日利亚阿达马瓦州三个地方政府辖区(LGA)的发热患者进行登革病毒感染的血清学和分子调查。通过酶联免疫吸附测定法(CALBIOTECH,登革病毒IgM ELISA)对424名患者的血清样本进行分析。采用厚涂片和薄涂片显微镜技术确定疟原虫的存在。总体而言,在三个研究地点,19.4%的患者登革热血清学检测呈阳性。在穆比、吉梅塔和努曼,分别有11%、14.5%和12.3%的参与者被发现同时感染了登革热和疟疾。使用美国疾病控制与预防中心(CDC)的DENV1 - 4逆转录聚合酶链反应(RT - PCR)检测试剂对流行血清型进行血清型特异性检测和鉴定。通过实时荧光定量PCR和测序,从ELISA阳性样本中确认有11例(2.6%)为登革热1型病例,且在所有三个研究区域均有流行。鉴于总体血清流行率为19.4%,登革病毒感染可能是研究地点发热疾病的主要原因之一;因此,公共卫生保健专业人员不应忽视发热疾病的其他病因以及进行实验室诊断以确定发热疾病可能病因的必要性。